Semaglutide with B12 for Injection recalled over sterility concerns
- Recall date
- July 30, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- GenoGenix LLC recalls Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton…
- Recall number
- D-0083-2026
- FDA classification
- Class II
- Brand / firm
- GenoGenix LLC
- Sold / distributed
- US Nationwide.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
Get recall alerts
Free email alert whenever GenoGenix LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: GenoGenix LLC